USPTO serial 79043527
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Roberta S. Bren
Roberta S. Bren Oblon, McClelland, Maier & Neustadt, L.L.P.1940 Duke StreetAlexandria, VA 22314UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in industry and science, namely, enzymes for scientific and research purposes; chemical products for in-vitro use in laboratories and for analysis, namely, enzymes and chemicals for use in gene delivery technology for laboratory and research use; micro-organisms for laboratory and research use, cell cultures for laboratory and research use, plasmids and cultures of micro organisms for laboratory and research use, deoxyribonucleic acid sequences for laboratory and research use, cloning vehicles, namely, chemical preparations for scientific purposes for use in biotechnology, research and development and recombinant deoxyribonucleic acid variations thereof for laboratory and research use, all for in-vivo use | SECTION 71 - CANCELLED | — |
| 005 | Gene therapy and prophylaxis products, namely, gene delivery pharmaceuticals; pharmaceuticals for the delivery of genes to muscle cells, all for medical purposes; vaccines, enzymes, and enzyme preparations for the treatment of cancer; hypoxia response pharmaceutical substances and preparations, viral and retroviral vectors, viral and retroviral vector manufacturing preparations for the treatment of cancer; pharmaceutical and biochemical preparations for the treatment of cancer | SECTION 71 - CANCELLED | — |
| 010 | Instruments and apparatus for the administration of gene therapy vaccines and prophylaxis preparations and substances and pre-filled vials, syringes and injectors containing pharmaceuticals for the treatment of cancer sold as a unit | SECTION 71 - CANCELLED | — |
| 042 | Scientific and medical research and development; genetic engineering services for scientific purposes; biotechnology services, namely, research and development in the field of biotechnology and providing information on the subject of scientific research in the field of biotechnology; scientific advisory services relating to gene therapy products and clinical trials, conducting clinical trials | SECTION 71 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 5, 2018 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Jan 5, 2018 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Apr 14, 2017 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jun 17, 2016 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jun 17, 2016 | INPC | INVALIDATION PROCESSED | — |
| Jun 16, 2016 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Oct 16, 2015 | C71T | CANCELLED SECTION 71 | — |
| Feb 9, 2015 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 12, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 23, 2009 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 23, 2009 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 10, 2009 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 10, 2009 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 23, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 3, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Nov 19, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 19, 2008 | ALIE | ASSIGNED TO LIE | — |
| Nov 13, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 13, 2008 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 13, 2008 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 13, 2008 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 13, 2008 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 13, 2008 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Nov 13, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 4, 2008 | GEA1 | NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED | — |
| Nov 4, 2008 | GECD | ACTION DENYING REQ FOR RECON E-MAILED | — |
| Nov 4, 2008 | CNCF | ACTION CONTINUING FINAL - COMPLETED | — |
| Oct 24, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 24, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 24, 2008 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| May 15, 2008 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 15, 2008 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 15, 2008 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 18, 2008 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 18, 2008 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 18, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 18, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 18, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 25, 2007 | RFNP | REFUSAL PROCESSED BY IB | — |
| Oct 19, 2007 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 19, 2007 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 19, 2007 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 18, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 12, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 12, 2007 | NWAP | NEW APPLICATION ENTERED | — |
| Oct 11, 2007 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |